SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Morgan Stanley Raises Moderna Price Target to $200 From $95, Maintains Equalweight

Morgan Stanley raised its price target on Moderna to $200 from $95 and maintained its Equalweight rating.

MRNA

Related stories